Cargando…

Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia

BACKGROUND: Ethiopia is one of the Sub-Saharan African countries with an increasingly risky sexual practice and mostly affected by the Human Immunodeficiency Virus (HIV) epidemic. Dual protection is an important preventive approach which can prevent both unwanted pregnancy and sexually transmitted i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilahun, Yohannes, Bala, Elias Teferi, Bulto, Gizachew Abdissa, Roga, Ephrem Yohannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894880/
https://www.ncbi.nlm.nih.gov/pubmed/33623452
http://dx.doi.org/10.2147/RMHP.S290362
_version_ 1783653318344572928
author Tilahun, Yohannes
Bala, Elias Teferi
Bulto, Gizachew Abdissa
Roga, Ephrem Yohannes
author_facet Tilahun, Yohannes
Bala, Elias Teferi
Bulto, Gizachew Abdissa
Roga, Ephrem Yohannes
author_sort Tilahun, Yohannes
collection PubMed
description BACKGROUND: Ethiopia is one of the Sub-Saharan African countries with an increasingly risky sexual practice and mostly affected by the Human Immunodeficiency Virus (HIV) epidemic. Dual protection is an important preventive approach which can prevent both unwanted pregnancy and sexually transmitted infections including HIV/AIDS. Therefore, this study aimed to assess the dual contraceptive utilization and associated factors among reproductive-age women on Anti-Retroviral Therapy (ART) in central Ethiopia. METHODS: An-institution based cross-sectional study was conducted among 311 women on ART at public hospitals of West Shewa Zone from June to September 2019. A systematic random sampling technique was used to select the study participants. A pretested structured interviewer-administered questionnaire was used for data collection. The data were entered into Epi data version 3.1 and exported to IBM SPSS statistical software version 25 for analysis. Bivariate and multivariable logistic regression analysis were computed. Odds ratio along with 95% confidence interval was computed to ascertain the association. RESULTS: The prevalence of dual contraceptive utilization among women on ART was 21.4% (95% CI: 16.8–25.9). Age of respondents between 15 and 24 years [AOR=8.35, (95% CI: 3.12–17.78)], living in urban [AOR=2.59, 95% CI: 1.15–4.22], separated women [AOR=2.28, 95% CI (1.26–5.04)], had post-diagnosis counselling on family planning [AOR=5.33, 95% CI: 1.52–18.68], disclosed HIV status [AOR=5.98, 95% CI: 1.63–21.93], freely discuss with their husband [AOR=4.22, 95% CI, 1.84–12.36], have no fertility desire [AOR=2.46, (95% CI: 1.34–6.44)] were significantly associated with dual contraceptive utilization. CONCLUSION AND RECOMMENDATION: The overall magnitude of dual contraceptive utilization among women on ART was found to be low. Factors like age, residence, marital status, post-diagnosis counselling, disclosure of HIV status, and free discussion with husband were significantly associated with dual contraceptive method utilization. Therefore, it is necessary to expand the range of strategies and tools available to married and single women’s for protecting themselves from being infected with other strains and pregnancy. The concerned stakeholders also should emphatically consider those identified factors for intervention.
format Online
Article
Text
id pubmed-7894880
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78948802021-02-22 Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia Tilahun, Yohannes Bala, Elias Teferi Bulto, Gizachew Abdissa Roga, Ephrem Yohannes Risk Manag Healthc Policy Original Research BACKGROUND: Ethiopia is one of the Sub-Saharan African countries with an increasingly risky sexual practice and mostly affected by the Human Immunodeficiency Virus (HIV) epidemic. Dual protection is an important preventive approach which can prevent both unwanted pregnancy and sexually transmitted infections including HIV/AIDS. Therefore, this study aimed to assess the dual contraceptive utilization and associated factors among reproductive-age women on Anti-Retroviral Therapy (ART) in central Ethiopia. METHODS: An-institution based cross-sectional study was conducted among 311 women on ART at public hospitals of West Shewa Zone from June to September 2019. A systematic random sampling technique was used to select the study participants. A pretested structured interviewer-administered questionnaire was used for data collection. The data were entered into Epi data version 3.1 and exported to IBM SPSS statistical software version 25 for analysis. Bivariate and multivariable logistic regression analysis were computed. Odds ratio along with 95% confidence interval was computed to ascertain the association. RESULTS: The prevalence of dual contraceptive utilization among women on ART was 21.4% (95% CI: 16.8–25.9). Age of respondents between 15 and 24 years [AOR=8.35, (95% CI: 3.12–17.78)], living in urban [AOR=2.59, 95% CI: 1.15–4.22], separated women [AOR=2.28, 95% CI (1.26–5.04)], had post-diagnosis counselling on family planning [AOR=5.33, 95% CI: 1.52–18.68], disclosed HIV status [AOR=5.98, 95% CI: 1.63–21.93], freely discuss with their husband [AOR=4.22, 95% CI, 1.84–12.36], have no fertility desire [AOR=2.46, (95% CI: 1.34–6.44)] were significantly associated with dual contraceptive utilization. CONCLUSION AND RECOMMENDATION: The overall magnitude of dual contraceptive utilization among women on ART was found to be low. Factors like age, residence, marital status, post-diagnosis counselling, disclosure of HIV status, and free discussion with husband were significantly associated with dual contraceptive method utilization. Therefore, it is necessary to expand the range of strategies and tools available to married and single women’s for protecting themselves from being infected with other strains and pregnancy. The concerned stakeholders also should emphatically consider those identified factors for intervention. Dove 2021-02-15 /pmc/articles/PMC7894880/ /pubmed/33623452 http://dx.doi.org/10.2147/RMHP.S290362 Text en © 2021 Tilahun et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tilahun, Yohannes
Bala, Elias Teferi
Bulto, Gizachew Abdissa
Roga, Ephrem Yohannes
Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title_full Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title_fullStr Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title_full_unstemmed Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title_short Dual Contraceptive Utilization and Associated Factors Among Reproductive-Age Women on Anti-Retroviral Therapy at Hospitals in Central Ethiopia
title_sort dual contraceptive utilization and associated factors among reproductive-age women on anti-retroviral therapy at hospitals in central ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894880/
https://www.ncbi.nlm.nih.gov/pubmed/33623452
http://dx.doi.org/10.2147/RMHP.S290362
work_keys_str_mv AT tilahunyohannes dualcontraceptiveutilizationandassociatedfactorsamongreproductiveagewomenonantiretroviraltherapyathospitalsincentralethiopia
AT balaeliasteferi dualcontraceptiveutilizationandassociatedfactorsamongreproductiveagewomenonantiretroviraltherapyathospitalsincentralethiopia
AT bultogizachewabdissa dualcontraceptiveutilizationandassociatedfactorsamongreproductiveagewomenonantiretroviraltherapyathospitalsincentralethiopia
AT rogaephremyohannes dualcontraceptiveutilizationandassociatedfactorsamongreproductiveagewomenonantiretroviraltherapyathospitalsincentralethiopia